AMLX — Amylyx Pharmaceuticals, Inc. stock price, charts and financials

QT72Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
32.41
-1.53-4.51%
OverviewShort InterestFilings
AMLXQT72Amylyx Pharmaceuticals, Inc.·NASDAQ
32.41-4.51%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 08, 20268-KCurrent report
Sep 02, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 2026424B5Prospectus
Aug 20, 20268-KCurrent report
Aug 18, 20268-KCurrent report
Aug 18, 20268-KCurrent report
Aug 18, 2026424B5Prospectus
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 13, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
#1 / 25 of 377
Page
▼
/ 16